T1	Participants 21 42	obese type 2 diabetes
T2	Participants 303 371	21 obese subjects imperfectly controlled by 20 mg of glyburide daily
T3	Participants 1405 1482	obese persons with type 2 diabetes no longer responsive to oral therapy alone
